Tag: drug eluting stent market drivers

  • Drug Eluting Stent Market Forecast 2024-2033: Anticipated Size and Growth Trends

    Drug Eluting Stent Market Forecast 2024-2033: Anticipated Size and Growth Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Drug Eluting Stent Market from 2024 to 2033?
    The drug eluting stent market has shown strong growth in recent years. It will grow from $7.05 billion in 2023 to $7.63 billion in 2024, representing a CAGR of 8.2%. This growth is attributed to the need for improved treatment options, clinical evidence, regulatory approval, healthcare economics, and guidelines.

    The drug-eluting stent market is expected to see solid growth, projected to reach $10.52 billion by 2028 at a CAGR of 8.4%. Factors driving this growth include an aging population, chronic disease burden, expanded indications, healthcare reimbursement policies, and patient-centered care. Major trends include personalized medicine, minimally invasive techniques, emerging healthcare technologies, and next-generation drug formulations.

    Claim Your Free Sample of the Global Drug Eluting Stent Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp

    What Key Factors Are Fueling the Growth of the Drug Eluting Stent Market?
    The drug-eluting stent market is expected to grow due to the rising burden of coronary heart disease (CHD), characterized by narrowed or blocked coronary arteries. The prevalence of CHD is increasing due to lifestyle factors and an aging population. Drug-eluting stents help open these arteries and release medication to prevent re-narrowing. For instance, the CDC reported in May 2024 that the percentage of adults with CHD rose from 4.6% in 2020 to 4.9% in 2022. Thus, the rising burden of CHD is driving the drug-eluting stent market.

    What Are the Major Segments of the Drug Eluting Stent Market?
    1) By Product: Polymer-Based; Polymer-Free
    2) By Drug: Sirolimus; Paclitaxel; Zotarolimus; Everolimus; Biolimus; Other Drugs
    3) By Scaffold: Cobalt-Chromium; Platinum-Chromium; Nitinol; Biodegradable; Other Scaffolds
    4) By Application: Coronary Diseases; Peripheral Vascular Diseases
    5) By End-User: Hospitals; Specialty Clinic

    What New Trends Are Transforming the Drug Eluting Stent Market?
    Companies in the drug-eluting stent market are innovating delivery systems like the dual-layer balloon for better drug delivery. In August 2022, Medtronic launched the Onyx Frontier, which features design enhancements for improved performance.

    Order Now for Fast Delivery of Your Drug Eluting Stent Market Report!
    https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

    Which Regions Are Driving Growth in the Drug Eluting Stent Market?
    North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Drug Eluting Stent Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the drug eluting stent market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Drug Eluting Stent Market Include

    1. Drug Eluting Stent Market Executive Summary
    2. Drug Eluting Stent Market Segments
    3. Drug Eluting Stent Market Size And Template Market Growth Rate
    4.  Key Drug Eluting Stent Market Trends
    5. Major Drug Eluting Stent Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Drug Eluting Stent Market
    26. Top Drug Eluting Stent Companies
    27. Drug Eluting Stent Market Opportunities And Strategies
    28. Drug Eluting Stent Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Drug Eluting Balloons Catheters Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

    Bioabsorbable Stents Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

    Intracranial Stents Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s The Growth Forecast For Drug Eluting Stent Market Through 2024-2033?

    What’s The Growth Forecast For Drug Eluting Stent Market Through 2024-2033?

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Market Overview

    • 2023 Market Size:$7.05 billion
    • 2024 Projected Market Size:$7.63 billion
    • CAGR (2023-2024):2%

    The drug-eluting stent market has experienced strong growth due to the need for improved treatment options, advancements in clinical evidence, regulatory approvals, and healthcare economics. This trend is expected to continue as new technologies and patient-centered approaches emerge.

    Future Market Growth

    • 2028 Projected Market Size:$10.52 billion
    • CAGR (2024-2028):4%

    Growth in the market is anticipated to be driven by an aging population, increasing chronic disease burden, expanding indications for use, favorable healthcare reimbursement policies, and the push towards patient-centered care. Key trends include personalized medicine, minimally invasive techniques, and next-generation drug formulations.

    View More On The Drug Eluting Stent Market Report 2024 –
    https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

    Key Trends and Drivers

    • Impact of Coronary Heart Disease:The rising prevalence of coronary heart disease (CHD) is a significant driver for the drug-eluting stent market. CHD, characterized by the narrowing or blockage of coronary arteries due to plaque buildup, can lead to severe complications such as heart attacks. Drug-eluting stents help address this issue by releasing medication that prevents re-narrowing of arteries. For instance, data from the Centers for Disease Control and Prevention (CDC) indicated an increase in the prevalence of CHD among adults from 4.6% in 2020 to 4.9% in 2022.
    • Innovation in Stent Design:Companies are focusing on advancing drug-eluting stent technologies. For example, Medtronic’s Onyx Frontier, launched in August 2022, features a dual-layer balloon that improves drug delivery precision and stent deployment. This new generation of stents shows a 16% increase in deliverability compared to previous models.
    • Personalized Medicine and Minimally Invasive Techniques:The shift towards personalized medicine and minimally invasive techniques is enhancing treatment efficacy and patient outcomes. These advancements are leading to more precise and effective interventions.
    • Emerging Healthcare Technologies:Next-generation drug formulations and innovative delivery systems are pushing the boundaries of interventional cardiology, providing more effective solutions for coronary artery disease.

    Strategic Acquisitions

    • Cordis and MedAlliance:In October 2023, Cordis acquired MedAlliance, a move aimed at expanding its product portfolio in the coronary and peripheral vascular markets. MedAlliance’s expertise in drug-eluting stents aligns with Cordis’ goals to advance cardiovascular innovation.

    Market Segmentation

    • By Product: Polymer-Based, Polymer-Free
    • By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs
    • By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds
    • By Application: Coronary Diseases, Peripheral Vascular Diseases
    • By End-User: Hospitals, Specialty Clinics

    Regional Insights

    • North America:The largest market region in 2023, driven by advanced healthcare infrastructure and high adoption rates of new technologies.
    • Asia-Pacific:Expected to be the fastest-growing region, fueled by increasing healthcare investments, rising prevalence of cardiovascular diseases, and expanding access to advanced medical technologies.

    Conclusion

    The drug-eluting stent market is set for continued strong growth, driven by advancements in technology, increasing prevalence of coronary heart disease, and a shift towards personalized and minimally invasive treatments. Innovations in stent design and strategic acquisitions are shaping the future landscape of this market.

    Request A Sample Of The Global Drug Eluting Stent Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15557&type=smp